Zylox
Hangzhou · Founded 2012
About Zylox
Zylox Medical Device Co. was founded in the beautiful city of Hangzhou in 2012 by a group of highly skillful and experienced returnees from the US and Europe. They have on average 5-20 years of working experiences in various functional areas such as research and development, management, and manufacturing in leading device makers including Johnson & Johnson, Medtronic, and Abbott before returning to China. Since its inception, Zylox has developed an increasingly rich product pipeline of interventional and implantable peripheral vascular devices such as PTA balloons, PTA drug-coated Balloons (PTA DCB), superficial femoral artery (SFA) stent, drug-eluting SFA stent, and other vascular accessories. Zylox strives to continuously innovate and provide patients with superior quality medical devices.
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $66.8M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2020)
- Website: zyloxmedical.com
- Phone: (+86) 571 8861 0082
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/zylox-104087 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.